Trifluridine: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
Antiviral | Antiviral | ||
==US Brand Names== | ==US Brand Names== | ||
VIROPTIC<sup>®</sup> | VIROPTIC<sup>®</sup>(Zelitrex) | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[Trifluridine description|Description]]''' | ''' [[Trifluridine description|Description]]''' | ||
Revision as of 15:43, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
Antiviral
US Brand Names
VIROPTIC®(Zelitrex)
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages